Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06757062 · ClinicalTrials.gov registry record · NA

Efficacy of Red Kinesiology Tape on Carpal Tunnel-Like Symptoms and Performance in Esports Gamers

A NA study of Carpal Tunnel Syndrome, sponsored by University of Nevada, Las Vegas.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06757062: Recruiting NA study of Carpal Tunnel Syndrome, sponsored by University of Nevada, Las Vegas.

NCT06757062 is a NA study of Carpal Tunnel Syndrome that is actively recruiting participants, run by University of Nevada, Las Vegas. The registered enrollment target is 30 participants, below the 221-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06757062, a NA study of Carpal Tunnel Syndrome, is actively recruiting participants, sponsored by University of Nevada, Las Vegas.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn if dorsally applied kinesiology tape is an effective conservative treatment for symptoms of carpal tunnel syndrome and assess the potential performance effect of the tape color in first-person shooter esports games in esports gamers who exhibit symptoms that resemble carpal tunnel syndrome. The main questions it aims to answer are: Is dorsally applied kinesiology tape able to manage carpal tunnel syndrome-like symptoms in esports gamers? Does red kinesiology tape hinder or improve performance in first-person shooter esports games in esports gamers? Researchers will compare red kinesiology tape to skin tone kinesiology tape. Both will be applied on the dorsal aspect of the hand and wrist of the dominant upper extremity. Participants will visit the site 2 times to get kinesiology tape applied and complete a pre and post-test for pain and performance. Depending on randomization a participant will receive a random sequence of the study arm (ex: red then skin tone or skin tone then red tape)

Primary Outcome

Short Form - McGill Pain Questionnaire - 2 will give outcomes of pain intensity and quality. It includes adjectives to describe both nociceptive pain and neuropathic pain. Pain descriptors can be categorized into Continuous (throbbing pain, cramping pain, gnawing pain, aching pain, heavy pain, tender), Intermittent (shooting pain, stabbing pain, sharp pain, splitting pain, electric-shock pain, piercing), Neuropathic (hot-burning pain, cold-freezing pain, pain caused by light touch, itching, ting

Conditions Studied

Interventions

  • DEVICE Kinesiology Tape

Study Locations (1)

Nevada

  • University of Nevada, Las Vegas - Shadow Lane Campus - Las Vegas

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-01-01
Est. Completion 2025-04-30
Phase NA
University of Nevada, Las Vegas

52 total trials

What NCT06757062 shows while recruiting

NCT06757062 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 221-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Carpal Tunnel Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Kinesiology Tape is the first listed.

NCT06757062 reports a single indexed study location in Nevada.

Frequently Asked Questions

What is clinical trial NCT06757062 about?

NCT06757062 is a clinical study titled "Efficacy of Red Kinesiology Tape on Carpal Tunnel-Like Symptoms and Performance in Esports Gamers". The goal of this clinical trial is to learn if dorsally applied kinesiology tape is an effective conservative treatment for symptoms of carpal tunnel syndrome and assess the potential performance effect of the tape color in first-person shooter esports games in esports gamers who exhibit symptoms th...

What is the current status of trial NCT06757062?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-01-01. Estimated completion is 2025-04-30.

What conditions does trial NCT06757062 study?

This clinical trial studies the following conditions: Carpal Tunnel Syndrome.

What interventions are being tested in trial NCT06757062?

The interventions under investigation include: Kinesiology Tape (DEVICE).

Who is sponsoring clinical trial NCT06757062?

This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06757062 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Carpal Tunnel Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06757062's enrollment target sits among peer trials

30 22nd of 21 the lowest of 21 other Carpal Tunnel Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Carpal Tunnel Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06757062, the US trial registry maintained by the National Library of Medicine. NCT06757062 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.